サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1508577

臨床データ分析市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年

Clinical Data Analytics Market (Component: Services and Solutions, and Type: Prescriptive, Descriptive, and Predictive) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 156 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.58円
臨床データ分析市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年05月28日
発行: Transparency Market Research
ページ情報: 英文 156 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床データ分析市場- 調査範囲

TMRの調査レポート「臨床データ分析の世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の臨床データ分析市場の収益と予測を提供しています。また、2024年から2034年までの世界の臨床データ分析市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、臨床データ分析市場を推察しました。

市場スナップショット
2023年の市場規模 155億米ドル
2034年の市場規模 6,147億米ドル
CAGR 39.7%

当レポートでは、世界の臨床データ分析市場の競合情勢について調査しています。世界の臨床データ分析市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の臨床データ分析市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測, 2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：コンポーネント別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：コンポーネント別, 2020-2034年
    • サービス
    • ソリューション
  • 市場の魅力：コンポーネント別

第7章 世界の市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：タイプ別, 2020-2034年
    • 規範的
    • 概要的
    • 予測的
  • 市場の魅力：タイプ別

第8章 世界の市場分析と予測：展開タイプ別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：展開タイプ別, 2020-2034年
    • オンプレミス
    • クラウド上
  • 市場の魅力：展開タイプ別

第9章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：用途別, 2020-2034年
    • 品質改善と臨床ベンチマーク
    • 臨床意思決定支援
    • 規制報告とコンプライアンス
    • 比較分析/比較効果
    • 精密医療
  • 市場の魅力：用途別

第10章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：エンドユーザー別, 2020-2034年
    • ヘルスケア支払者
      • 公共
      • 民間
    • ヘルスケア提供者
      • 病院と診療所
      • 外来手術センター
      • 画像診断センター
      • その他（研究センター等）
  • 市場の魅力：エンドユーザー別

第11章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別, 2020-2034年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第12章 北米の市場分析と予測

第13章 欧州の市場分析と予測

第14章 アジア太平洋地域の市場分析と予測

第15章 ラテンアメリカの市場分析と予測

第16章 中東・アフリカの市場分析と予測

第17章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • CareEvolution
    • Veradigm
    • IQVIA
    • Oracle
    • Health Catalyst
    • IBM
    • InterSystems Corporation
    • Optum, Inc.
    • Koninklijke Philips N.V.
    • MedeAnalytics
    • Sisense
図表

List of Tables

  • Table 01: Global Clinical Data Analytics Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 02: Global Clinical Data Analytics Market Size (US$ Bn) Forecast, by Type, 2020-2034
  • Table 03: Global Clinical Data Analytics Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 04: Global Clinical Data Analytics Market Size (US$ Bn) Forecast, By Deployment Type, 2020-2034
  • Table 05: Global Clinical Data Analytics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 06: Global Clinical Data Analytics Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 07: North America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 08: North America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 09: North America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Type, 2020-2034
  • Table 10: North America Clinical Data Analytics Market Size (US$ Bn) Forecast, By Deployment Type, 2020-2034
  • Table 11: North America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 12: North America Clinical Data Analytics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Europe Clinical Data Analytics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Europe Clinical Data Analytics Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 15: Europe Clinical Data Analytics Market Size (US$ Bn) Forecast, by Type, 2020-2034
  • Table 16: Europe Clinical Data Analytics Market Size (US$ Bn) Forecast, By Deployment Type, 2020-2034
  • Table 17: Europe Clinical Data Analytics Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 18: Europe Clinical Data Analytics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 19: Asia Pacific Clinical Data Analytics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 20: Asia Pacific Clinical Data Analytics Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 21: Asia Pacific Clinical Data Analytics Market Size (US$ Bn) Forecast, by Type, 2020-2034
  • Table 22: Asia Pacific Clinical Data Analytics Market Size (US$ Bn) Forecast, By Deployment Type, 2020-2034
  • Table 23: Asia Pacific Clinical Data Analytics Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 24: Asia Pacific Clinical Data Analytics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 25: Latin America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 26: Latin America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 27: Latin America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Type, 2020-2034
  • Table 28: Latin America Clinical Data Analytics Market Size (US$ Bn) Forecast, By Deployment Type, 2020-2034
  • Table 29: Latin America Clinical Data Analytics Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 30: Latin America Clinical Data Analytics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 31: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 32: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 33: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast, by Type, 2020-2034
  • Table 34: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast, By Deployment Type, 2020-2034
  • Table 35: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 36: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Clinical Data Analytics Market Size (US$ Bn) and Distribution (%), by Region, 2023. and 2034
  • Figure 02: Global Clinical Data Analytics Market Revenue (US$ Bn), by Component, 2023
  • Figure 03: Global Clinical Data Analytics Market Value Share, by Component, 2023
  • Figure 04: Global Clinical Data Analytics Market Revenue (US$ Bn), by Type, 2023
  • Figure 05: Global Clinical Data Analytics Market Value Share, by Type, 2023
  • Figure 06: Global Clinical Data Analytics Market Revenue (US$ Bn), By Deployment Type, 2023
  • Figure 07: Global Clinical Data Analytics Market Value Share, By Deployment Type, 2023
  • Figure 08: Global Clinical Data Analytics Market Revenue (US$ Bn), by Application, 2023
  • Figure 09: Global Clinical Data Analytics Market Value Share, by Application, 2023
  • Figure 10: Global Clinical Data Analytics Market Revenue (US$ Bn), by End-user, 2023
  • Figure 11: Global Clinical Data Analytics Market Value Share, by End-user, 2023
  • Figure 12: Global Clinical Data Analytics Market Value Share, by Region, 2023
  • Figure 13: Global Clinical Data Analytics Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 14: Global Clinical Data Analytics Market Value Share Analysis, by Component, 2023. and 2034
  • Figure 15: Global Clinical Data Analytics Market Attractiveness Analysis, by Component, 2024-2034
  • Figure 16: Global Clinical Data Analytics Market Value Share Analysis, by Type, 2023. and 2034
  • Figure 17: Global Clinical Data Analytics Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 18: Global Clinical Data Analytics Market Value Share Analysis, By Deployment Type, 2023. and 2034
  • Figure 19: Global Clinical Data Analytics Market Attractiveness Analysis, By Deployment Type, 2024-2034
  • Figure 20: Global Clinical Data Analytics Market Revenue (US$ Bn), by Application, 2023
  • Figure 21: Global Clinical Data Analytics Market Value Share, by Application, 2023
  • Figure 22: Global Clinical Data Analytics Market Revenue (US$ Bn), by End-user, 2023
  • Figure 23: Global Clinical Data Analytics Market Value Share, by End-user, 2023
  • Figure 24: Global Clinical Data Analytics Market Value Share Analysis, by Region, 2023. and 2034
  • Figure 25: Global Clinical Data Analytics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 26: North America Clinical Data Analytics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 27: North America Clinical Data Analytics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 28: North America Clinical Data Analytics Market Value Share Analysis, by Country, 2023. and 2034
  • Figure 29: North America Clinical Data Analytics Market Value Share Analysis, by Component, 2023. and 2034
  • Figure 30: North America Clinical Data Analytics Market Value Share Analysis, by Type, 2023. and 2034
  • Figure 31: North America Clinical Data Analytics Market Value Share Analysis, By Deployment Type, 2023. and 2034
  • Figure 32: North America Clinical Data Analytics Market Value Share Analysis, by Application, 2023. and 2034
  • Figure 33: North America Clinical Data Analytics Market Value Share Analysis, by End-user, 2023. and 2034
  • Figure 34: North America Clinical Data Analytics Market Attractiveness Analysis, by Component, 2024-2034
  • Figure 35: North America Clinical Data Analytics Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 36: North America Clinical Data Analytics Market Attractiveness Analysis, By Deployment Type, 2023-2034
  • Figure 37: North America Clinical Data Analytics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 38: North America Clinical Data Analytics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 39: Europe Clinical Data Analytics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 40: Europe Clinical Data Analytics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 41: Europe Clinical Data Analytics Market Value Share Analysis, by Country/Sub-region, 2023. and 2034
  • Figure 42: Europe Clinical Data Analytics Market Value Share Analysis, by Component, 2023. and 2034
  • Figure 43: Europe Clinical Data Analytics Market Value Share Analysis, by Type, 2023. and 2034
  • Figure 44: Europe Clinical Data Analytics Market Value Share Analysis, By Deployment Type, 2023. and 2034
  • Figure 45: Europe Clinical Data Analytics Market Value Share Analysis, by Application, 2023. and 2034
  • Figure 46: Europe Clinical Data Analytics Market Value Share Analysis, by End-user, 2023. and 2034
  • Figure 47: Europe Clinical Data Analytics Market Attractiveness Analysis, by Component, 2024-2034
  • Figure 48: Europe Clinical Data Analytics Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 49: Europe Clinical Data Analytics Market Attractiveness Analysis, By Deployment Type, 2024-2034
  • Figure 50: Europe Clinical Data Analytics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 51: Europe Clinical Data Analytics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 52: Asia Pacific Clinical Data Analytics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 53: Asia Pacific Clinical Data Analytics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 54: Asia Pacific Clinical Data Analytics Market Value Share Analysis, by Country/Sub-region, 2023. and 2034
  • Figure 55: Asia Pacific Clinical Data Analytics Market Value Share Analysis, by Component, 2023. and 2034
  • Figure 56: Asia Pacific Clinical Data Analytics Market Value Share Analysis, by Type, 2023. and 2034
  • Figure 57: Asia Pacific Clinical Data Analytics Market Value Share Analysis, By Deployment Type, 2023. and 2034
  • Figure 58: Asia Pacific Clinical Data Analytics Market Value Share Analysis, by Application, 2023. and 2034
  • Figure 59: Asia Pacific Clinical Data Analytics Market Value Share Analysis, by End-user, 2023. and 2034
  • Figure 60: Asia Pacific Clinical Data Analytics Market Attractiveness Analysis, by Component, 2024-2034
  • Figure 61: Asia Pacific Clinical Data Analytics Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 62: Asia Pacific Clinical Data Analytics Market Attractiveness Analysis, By Deployment Type, 2024-2034
  • Figure 63: Asia Pacific Clinical Data Analytics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 64: Asia Pacific Clinical Data Analytics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 65: Latin America Clinical Data Analytics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 66: Latin America Clinical Data Analytics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 67: Latin America Clinical Data Analytics Market Value Share Analysis, by Country/Sub-region, 2023. and 2034
  • Figure 68: Latin America Clinical Data Analytics Market Value Share Analysis, by Component, 2023. and 2034
  • Figure 69: Latin America Clinical Data Analytics Market Value Share Analysis, by Type, 2023. and 2034
  • Figure 70: Latin America Clinical Data Analytics Market Value Share Analysis, By Deployment Type, 2023. and 2034
  • Figure 71: Latin America Clinical Data Analytics Market Value Share Analysis, by Application, 2023. and 2034
  • Figure 72: Latin America Clinical Data Analytics Market Value Share Analysis, by End-user, 2023. and 2034
  • Figure 73: Latin America Clinical Data Analytics Market Attractiveness Analysis, by Component, 2024-2034
  • Figure 74: Latin America Clinical Data Analytics Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 75: Latin America Clinical Data Analytics Market Attractiveness Analysis, By Deployment Type, 2023-2034
  • Figure 76: Latin America Clinical Data Analytics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 77: Latin America Clinical Data Analytics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 78: Middle East & Africa Clinical Data Analytics Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 79: Middle East & Africa Clinical Data Analytics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 80: Middle East & Africa Clinical Data Analytics Market Value Share Analysis, by Country/Sub-region, 2023. and 2034
  • Figure 81: Middle East & Africa Clinical Data Analytics Market Value Share Analysis, by Component, 2023. and 2034
  • Figure 82: Middle East & Africa Clinical Data Analytics Market Value Share Analysis, by Type, 2023. and 2034
  • Figure 83: Middle East & Africa Clinical Data Analytics Market Value Share Analysis, By Deployment Type, 2023. and 2034
  • Figure 84: Middle East & Africa Clinical Data Analytics Market Value Share Analysis, by Application, 2023. and 2034
  • Figure 85: Middle East & Africa Clinical Data Analytics Market Value Share Analysis, by End-user, 2023. and 2034
  • Figure 86: Middle East & Africa Clinical Data Analytics Market Attractiveness Analysis, by Component, 2024-2034
  • Figure 87: Middle East & Africa Clinical Data Analytics Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 88: Middle East & Africa Clinical Data Analytics Market Attractiveness Analysis, By Deployment Type, 2023-2034
  • Figure 89: Middle East & Africa Clinical Data Analytics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 90: Middle East & Africa Clinical Data Analytics Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL86145

Clinical Data Analytics Market - Scope of Report

TMR's report on the global clinical data analytics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global clinical data analytics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical data analytics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical data analytics market.

Market Snapshot
Market Value in 2023US$ 15.5 Bn
Market Value in 2034US$ 614.7 Bn
CAGR39.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical data analytics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical data analytics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical data analytics market.

The report delves into the competitive landscape of the global clinical data analytics market. Key players operating in the global clinical data analytics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical data analytics market profiled in this report.

Key Questions Answered in Global clinical data analytics Market Report:

  • What is the sales/revenue generated by clinical data analytics across all regions during the forecast period?
  • What are the opportunities in the global clinical data analytics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Clinical Data Analytics Market - Research Objectives and Research Approach

The comprehensive report on the global clinical data analytics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global clinical data analytics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical data analytics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Clinical Data Analytics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Clinical Data Analytics Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Clinical Data Analytics Market Analysis and Forecast, by Component

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Component, 2020-2034
    • 6.3.1. Services
    • 6.3.2. Solutions
  • 6.4. Market Attractiveness, by Component

7. Global Clinical Data Analytics Market Analysis and Forecast, by Type

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type, 2020-2034
    • 7.3.1. Prescriptive
    • 7.3.2. Descriptive
    • 7.3.3. Predictive
  • 7.4. Market Attractiveness, by Type

8. Global Clinical Data Analytics Market Analysis and Forecast, By Deployment Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Deployment Type, 2020-2034
    • 8.3.1. On-premises
    • 8.3.2. On-cloud
  • 8.4. Market Attractiveness, By Deployment Type

9. Global Clinical Data Analytics Market Analysis and Forecast, by Application

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Application, 2020-2034
    • 9.3.1. Quality Improvement and Clinical Benchmarking
    • 9.3.2. Clinical Decision Support
    • 9.3.3. Regulatory Reporting and Compliance
    • 9.3.4. Comparative Analytics/Comparative Effectiveness
    • 9.3.5. Precision Health
  • 9.4. Market Attractiveness, by Application

10. Global Clinical Data Analytics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2020-2034
    • 10.3.1. Healthcare Payers
      • 10.3.1.1. Public
      • 10.3.1.2. Private
    • 10.3.2. Healthcare Providers
      • 10.3.2.1. Hospitals and Clinics
      • 10.3.2.2. Ambulatory Surgical Centers
      • 10.3.2.3. Diagnostic Imaging Centers
      • 10.3.2.4. Others (Research Centers, etc.)
  • 10.4. Market Attractiveness, by End-user

11. Global Clinical Data Analytics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020-2034
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Clinical Data Analytics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Component, 2020-2034
    • 12.2.1. Services
    • 12.2.2. Solutions
  • 12.3. Market Attractiveness, by Component
  • 12.4. Market Value Forecast, by Type, 2020-2034
    • 12.4.1. Prescriptive
    • 12.4.2. Descriptive
    • 12.4.3. Predictive
  • 12.5. Market Attractiveness, by Type
  • 12.6. Market Value Forecast, By Deployment Type, 2020-2034
    • 12.6.1. On-premises
    • 12.6.2. On-cloud
  • 12.7. Market Attractiveness, By Deployment Type
  • 12.8. Market Value Forecast, by Application, 2020-2034
    • 12.8.1. Quality Improvement and Clinical Benchmarking
    • 12.8.2. Clinical Decision Support
    • 12.8.3. Regulatory Reporting and Compliance
    • 12.8.4. Comparative Analytics/Comparative Effectiveness
    • 12.8.5. Precision Health
  • 12.9. Market Attractiveness, by Application
  • 12.10. Market Value Forecast, by End-user, 2020-2034
    • 12.10.1. Healthcare Payers
      • 12.10.1.1. Public
      • 12.10.1.2. Private
    • 12.10.2. Healthcare Providers
      • 12.10.2.1. Hospitals and Clinics
      • 12.10.2.2. Ambulatory Surgical Centers
      • 12.10.2.3. Diagnostic Imaging Centers
      • 12.10.2.4. Others (Research Centers, etc.)
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Component
    • 12.13.2. By Type
    • 12.13.3. By Deployment Type
    • 12.13.4. By Application
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Clinical Data Analytics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Component, 2020-2034
    • 13.2.1. Services
    • 13.2.2. Solutions
  • 13.3. Market Attractiveness, by Component
  • 13.4. Market Value Forecast, by Type, 2020-2034
    • 13.4.1. Prescriptive
    • 13.4.2. Descriptive
    • 13.4.3. Predictive
  • 13.5. Market Attractiveness, by Type
  • 13.6. Market Value Forecast, By Deployment Type, 2020-2034
    • 13.6.1. On-premises
    • 13.6.2. On-cloud
  • 13.7. Market Attractiveness, By Deployment Type
  • 13.8. Market Value Forecast, by Application, 2020-2034
    • 13.8.1. Quality Improvement and Clinical Benchmarking
    • 13.8.2. Clinical Decision Support
    • 13.8.3. Regulatory Reporting and Compliance
    • 13.8.4. Comparative Analytics/Comparative Effectiveness
    • 13.8.5. Precision Health
  • 13.9. Market Attractiveness, by Application
  • 13.10. Market Value Forecast, by End-user, 2020-2034
    • 13.10.1. Healthcare Payers
      • 13.10.1.1. Public
      • 13.10.1.2. Private
    • 13.10.2. Healthcare Providers
      • 13.10.2.1. Hospitals and Clinics
      • 13.10.2.2. Ambulatory Surgical Centers
      • 13.10.2.3. Diagnostic Imaging Centers
      • 13.10.2.4. Others (Research Centers, etc.)
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Component
    • 13.13.2. By Type
    • 13.13.3. By Deployment Type
    • 13.13.4. By Application
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Clinical Data Analytics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Component, 2020-2034
    • 14.2.1. Services
    • 14.2.2. Solutions
  • 14.3. Market Attractiveness, by Component
  • 14.4. Market Value Forecast, by Type, 2020-2034
    • 14.4.1. Prescriptive
    • 14.4.2. Descriptive
    • 14.4.3. Predictive
  • 14.5. Market Attractiveness, by Type
  • 14.6. Market Value Forecast, By Deployment Type, 2020-2034
    • 14.6.1. On-premises
    • 14.6.2. On-cloud
  • 14.7. Market Attractiveness, By Deployment Type
  • 14.8. Market Value Forecast, by Application, 2020-2034
    • 14.8.1. Quality Improvement and Clinical Benchmarking
    • 14.8.2. Clinical Decision Support
    • 14.8.3. Regulatory Reporting and Compliance
    • 14.8.4. Comparative Analytics/Comparative Effectiveness
    • 14.8.5. Precision Health
  • 14.9. Market Attractiveness, by Application
  • 14.10. Market Value Forecast, by End-user, 2020-2034
    • 14.10.1. Healthcare Payers
      • 14.10.1.1. Public
      • 14.10.1.2. Private
    • 14.10.2. Healthcare Providers
      • 14.10.2.1. Hospitals and Clinics
      • 14.10.2.2. Ambulatory Surgical Centers
      • 14.10.2.3. Diagnostic Imaging Centers
      • 14.10.2.4. Others (Research Centers, etc.)
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Component
    • 14.13.2. By Type
    • 14.13.3. By Deployment Type
    • 14.13.4. By Application
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Clinical Data Analytics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Component, 2020-2034
    • 15.2.1. Services
    • 15.2.2. Solutions
  • 15.3. Market Attractiveness, by Component
  • 15.4. Market Value Forecast, by Type, 2020-2034
    • 15.4.1. Prescriptive
    • 15.4.2. Descriptive
    • 15.4.3. Predictive
  • 15.5. Market Attractiveness, by Type
  • 15.6. Market Value Forecast, By Deployment Type, 2020-2034
    • 15.6.1. On-premises
    • 15.6.2. On-cloud
  • 15.7. Market Attractiveness, By Deployment Type
  • 15.8. Market Value Forecast, by Application, 2020-2034
    • 15.8.1. Quality Improvement and Clinical Benchmarking
    • 15.8.2. Clinical Decision Support
    • 15.8.3. Regulatory Reporting and Compliance
    • 15.8.4. Comparative Analytics/Comparative Effectiveness
    • 15.8.5. Precision Health
  • 15.9. Market Attractiveness, by Application
  • 15.10. Market Value Forecast, by End-user, 2020-2034
    • 15.10.1. Healthcare Payers
      • 15.10.1.1. Public
      • 15.10.1.2. Private
    • 15.10.2. Healthcare Providers
      • 15.10.2.1. Hospitals and Clinics
      • 15.10.2.2. Ambulatory Surgical Centers
      • 15.10.2.3. Diagnostic Imaging Centers
      • 15.10.2.4. Others (Research Centers, etc.)
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Component
    • 15.13.2. By Type
    • 15.13.3. By Deployment Type
    • 15.13.4. By Application
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Clinical Data Analytics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Component, 2020-2034
    • 16.2.1. Services
    • 16.2.2. Solutions
  • 16.3. Market Attractiveness, by Component
  • 16.4. Market Value Forecast, by Type, 2020-2034
    • 16.4.1. Prescriptive
    • 16.4.2. Descriptive
    • 16.4.3. Predictive
  • 16.5. Market Attractiveness, by Type
  • 16.6. Market Value Forecast, By Deployment Type, 2020-2034
    • 16.6.1. On-premises
    • 16.6.2. On-cloud
  • 16.7. Market Attractiveness, By Deployment Type
  • 16.8. Market Value Forecast, by Application, 2020-2034
    • 16.8.1. Quality Improvement and Clinical Benchmarking
    • 16.8.2. Clinical Decision Support
    • 16.8.3. Regulatory Reporting and Compliance
    • 16.8.4. Comparative Analytics/Comparative Effectiveness
    • 16.8.5. Precision Health
  • 16.9. Market Attractiveness, by Application
  • 16.10. Market Value Forecast, by End-user, 2020-2034
    • 16.10.1. Healthcare Payers
      • 16.10.1.1. Public
      • 16.10.1.2. Private
    • 16.10.2. Healthcare Providers
      • 16.10.2.1. Hospitals and Clinics
      • 16.10.2.2. Ambulatory Surgical Centers
      • 16.10.2.3. Diagnostic Imaging Centers
      • 16.10.2.4. Others (Research Centers, etc.)
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Component
    • 16.13.2. By Type
    • 16.13.3. By Deployment Type
    • 16.13.4. By Application
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2023)
  • 17.3. Company Profiles
    • 17.3.1. CareEvolution
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Veradigm
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. IQVIA
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Oracle
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Health Catalyst
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. IBM
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. InterSystems Corporation
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Optum, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Koninklijke Philips N.V.
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. MedeAnalytics
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview
    • 17.3.11. Sisense
      • 17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.11.2. Product Portfolio
      • 17.3.11.3. Financial Overview
      • 17.3.11.4. SWOT Analysis
      • 17.3.11.5. Strategic Overview